The insulin receptor and IGF-1 receptor are widely expressed in breast cancer cells and promote cell proliferation mainly via the insulin receptor substrate (IRS)/phosphatidylinositol 3-kinase (PI3K) and Ras/mitogen-activated protein kinase (MAPK) pathways (8, 39). Here, INSR is linked to breast cancer.